BioCentury | May 4, 2015
Clinical News

Samcyprone regulatory update

...has exclusive, worldwide rights from Hapten to develop and commercialize Samcyprone to treat dermatological diseases. Hapten Pharmaceuticals LLC...
Items per page:
1 - 1 of 1
BioCentury | May 4, 2015
Clinical News

Samcyprone regulatory update

...has exclusive, worldwide rights from Hapten to develop and commercialize Samcyprone to treat dermatological diseases. Hapten Pharmaceuticals LLC...
Items per page:
1 - 1 of 1